http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Cellectar Biosciences Announces Executive Leadership Changes
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings (SRGA) Granted FDA Clearance for HOLO Portal; Reports Prelim Q4 Results
-
Surgalign Receives FDA Clearance for HOLO Portal™ System, the World’s First AI-driven AR Guidance System for Spine Surgery and Reports Preliminary Fourth Quarter and Full Year 2021 Results
-
Surgalign Receives FDA Clearance for HOLO Portal™ System, the World’s First AI-driven AR Guidance System for Spine Surgery and Reports Preliminary Fourth Quarter and Full Year 2021 Results
-
Surgalign Holdings, Inc. to Participate at the Sidoti Virtual Small Cap Conference
-
Surgalign Holdings, Inc. to Participate at the Sidoti Virtual Small Cap Conference
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Expands Digital Health Capabilities with Acquisition of a Significant Equity Interest in Inteneural Networks Inc.
-
Surgalign Holdings, Inc. Expands Digital Health Capabilities with Acquisition of a Significant Equity Interest in Inteneural Networks Inc.
-
Surgalign Holdings, Inc. to Present at the 2022 H.C. Wainwright Virtual BioConnect Conference
-
Surgalign Holdings, Inc. to Present at the 2022 H.C. Wainwright Virtual BioConnect Conference
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
-
Surgalign Holdings, Inc. to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
-
Surgalign Holdings, Inc. Announces Third Quarter 2021 Results
-
Surgalign Holdings, Inc. Announces Third Quarter 2021 Results
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Schedules Third Quarter 2021 Earnings Release for November 9, 2021
-
Surgalign Holdings, Inc. Schedules Third Quarter 2021 Earnings Release for November 9, 2021
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings (SRGA) Announces CFO and COO Resignation
-
Surgalign Holdings Announces Management Changes
-
Surgalign Holdings Announces Management Changes
-
Surgalign Holdings (SRGA) Appoints Sheryl Conley as Board Chair
-
Surgalign Appoints Sheryl Conley as Chair of the Board of Directors
-
Surgalign Appoints Sheryl Conley as Chair of the Board of Directors
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings (SRGA) Announces Issuance of U.S. Patent Covering the Use of Artificial Intelligence in Medical Image Segmentation
-
Surgalign Announces Issuance of U.S. Patent Covering the Use of Artificial Intelligence in Medical Image Segmentation
-
Surgalign Announces Issuance of U.S. Patent Covering the Use of Artificial Intelligence in Medical Image Segmentation
-
Surgalign Holdings, Inc. Announces Second Quarter 2021 Results
-
Surgalign Holdings, Inc. Announces Second Quarter 2021 Results
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Schedules Second Quarter 2021 Earnings Release for August 6, 2021
-
Surgalign Holdings, Inc. Schedules Second Quarter 2021 Earnings Release for August 6, 2021
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. to Present at the Sidoti Virtual Investor Conference
-
Surgalign Holdings, Inc. to Present at the Sidoti Virtual Investor Conference
-
Surgalign Holdings Announces Collaboration with Inteneural Networks, a Leading Developer of Artificial Intelligence for Clinical Neurosciences
-
Surgalign Holdings Announces Collaboration with Inteneural Networks, a Leading Developer of Artificial Intelligence for Clinical Neurosciences
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

